UTICAJ DIJABETES MELITUSA NA DUGOROČNI MORTALITET KOD BOLESNIKA SA STEMI LEČENIH PRIMARNOM PCI
Sažetak
Uvod: Primarna PCI (PPCI) je zlatni standard u lečenju bolesnika sa akutnim infarktom miokarda (AIM) sa ST elevacijom (STEMI).
Cilj ove studije je da se ispita uticaj dijabetes melitusa (DM) na dugoročan mortalitet kod STEMI bolesnika lečenih PPCI tokom tri godine praćenja.
Materijal i metode: Analizirani su podaci 499 bolesnika sa STEMI, iz elektronske baze podataka Sale za kateterizaciju srca, Klinike za kardiologiju KCS, koja obuhvata period od 2009. do 2016. godine. Bolesnici su podeljeni u 2 grupe: sa dijabetes melitusom i bez dijabetes melitusa.
Zaključak: Kod bolesnika sa DM postoji povišen rizik od smrtnosti u kratkoročnom i dugoročnom praćenju nakon PPCI.
Ključne reči: DM, STEMI, PPCI
Introduction: Primary PCI (PPCI) is a gold standard in treating patients with acute myocardial infarction (AMI) with ST elevation (STEMI). The aim of this study is to evaluate the impact of diabetic status on admission on three year survival in patients with STEMI treated with PPCI.
Material and methods: We analyzed 499 STEMI patients treated with primary PCI, from a prospective, electronic database of the Clinical Center of Serbia Catheterization Laboratory that contains patient records from 2009 to 2016. Patients were divided into 2 groups: patients with DM and those without DM.
Conclusion: Patients with DM had higher unadjusted 30-day and 3-year mortality after PPCI.
Key words: DM, STEMI, PPCI
Reference
Baza podataka instituta za javno zdravlje Srbije „dr Milan Jovanović Batut“. Incidencija i mortalitet od akutnog koronarnog sindroma u Srbiji. 2015
Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, et al.; Atlantic Cardiovascular Patient Outcomes Research Team (CPORT). Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA.2002 Apr 17;287(15):1943-51.
Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. ; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003 Aug 21;349(8):733-42.
Hoebers LP, Claessen BE, Woudstra P, DeVries JH, Wykrzykowska JJ, Vis MM, et al. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
Republička stručna komisija za izradu i implementaciju vodiča dobre kliničke prakse. Agencija za akreditaciju zdravstvenih ustanova Srbije. Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje diabetes mellitus-a. Ministarstvo zdravlja Republike Srbije, 2012.
De Luca G, Gibson MC, Bellandi F, Noc M, Dudeke D, Zeymer U, et.al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis. 2009 Nov;207(1):181-5.
Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol.2009;54:2205-41.
MJ Garcia, PM McNamara, T Gordon and WB Kannel : Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes, 23 (1974), pp. 105–111
van der Schaaf RJ, Henriques JP, Wiersma JJ, Koch KT, Baan J Jr, Mulder KJ, et al. Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus.Heart. 2006;92:117-8.
Harjai KJ, Stone GW, Boura J, Mattos L, Chandra H, Cox D, et al. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol. 2003;91:1041-5.
Norhammar A, Lagerqvist B, Saleh N. Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention. 2010 Apr;5(8):891-7.
Timmer JR, van der Horst IC, Henriques JP, Thomas K, Bilo HJG, Hoorntje JCA,et al. Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial. Neth Heart J. 2003 Oct;11(10):387-393.
David RB, Almeida ED, Cruz LV, Sebben JC, Feijó IP, Schwarzer Schmidt KE et al. Diabetes Mellitus and Glucose as Predictors of Mortality in Primary Coronary Percutaneous Intervention. Arq Bras Cardiol. 2014 Oct; 103(4): 323–329.
Benamer H, Tafflet M, Bataille S, Escolano S, Livarek B, Fourchard V, et al. ; CARDIO-ARHIF Registry Investigators.Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry. EuroIntervention. 2011 Apr;6(9):1073-9.
Cooper S, Caldwell JH. Coronary Artery Disease in People With Diabetes: Diagnostic and Risk Factor Evaluation. Clinical diabetes. Vol. 17 No. 2 1999
Brand F, Abbott.R, Kannel W. Diabetes, Intermittent Claudication, and Risk of Cardiovascular Events: The Framingham Study. Diabetes 1989 Apr; 38(4): 504-509
Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King III SB et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002;90:1062–7.
Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239-42.
Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation.1995;91:635-40.
L. Monnier, M. Hanefeld, O. Schnell, C. Colette, D. Owens, Insulin and atherosclerosis: How are they related?, Diabetes & Metabolism, 2013, 39, 2, 11